Sana Biotechnology short interest was 46.21% of the float on March 31st, according to new data we received from Benzinga. Short interest totaled 39,379,007 shares, which was an increase of 4.96% from March 13th.
It is estimated that it would take 12.36 days for short sellers to buy back their shares, with current trading volumes.
Sana Biotechnology Hedge Fund Activity
We have seen 104 institutional investors add shares of Sana Biotechnology stock to their portfolio, and 77 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 6,538,436 shares (-99.8%) from their portfolio in Q4 2025, for an estimated $26,611,434
- BAILLIE GIFFORD & CO removed 4,827,438 shares (-42.2%) from their portfolio in Q4 2025, for an estimated $19,647,672
- BLACKROCK, INC. added 2,997,391 shares (+26.7%) to their portfolio in Q4 2025, for an estimated $12,199,381
- BAKER BROS. ADVISORS LP removed 1,720,466 shares (-84.7%) from their portfolio in Q4 2025, for an estimated $7,002,296
- BALYASNY ASSET MANAGEMENT L.P. added 1,679,130 shares (+inf%) to their portfolio in Q4 2025, for an estimated $6,834,059
- STATE STREET CORP added 1,374,300 shares (+20.6%) to their portfolio in Q4 2025, for an estimated $5,593,401
- VANGUARD GROUP INC added 1,326,222 shares (+14.5%) to their portfolio in Q4 2025, for an estimated $5,397,723
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Sana Biotechnology Analyst Ratings
Wall Street analysts have issued reports on $SANA in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 01/06/2026
- HC Wainwright & Co. issued a "Buy" rating on 11/07/2025
- Wedbush issued a "Outperform" rating on 11/07/2025
- Citizens issued a "Market Outperform" rating on 10/30/2025
To track analyst ratings and price targets for Sana Biotechnology, check out Quiver Quantitative's $SANA forecast page.
Sana Biotechnology Price Targets
Multiple analysts have issued price targets for $SANA recently. We have seen 4 analysts offer price targets for $SANA in the last 6 months, with a median target of $7.0.
Here are some recent targets:
- Emily Bodnar from HC Wainwright & Co. set a target price of $7.0 on 03/04/2026
- An analyst from B of A Securities set a target price of $7.0 on 01/06/2026
- Martin Fan from Wedbush set a target price of $6.0 on 11/07/2025
- Reni J. Benjamin from Citizens set a target price of $8.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
